drugset / Trial / NCT01918488

Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease

NCT01918488

Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of the study is to determine whether a diuretic drug called amiloride is capable of increasing renal salt excretion and thereby decrease blood pressure in diabetic patients with kidney disease. Our hypothesis states that amiloride is capable of reducing blood pressure in these patients and thus decrease the cardiovascular risk associated with diabetic kidney disease.

Timeline

Start
2013-10
Primary completion
2014-12
Completion

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiloride Small molecule 20 mg